Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.56 |
| ▸ | CTSG | P08311 | 2/20 | 0.56 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.56 |
| ▸ | CMA1 | P23946 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9331679 | 0.98 | GAA (0.57) | GAAKDM4EMAPK1SMN1; SMN2TSHR | |
| SCHEMBL27419582 | 0.93 | GPR139 (0.55) | GAAKDM4EMAPK1SMN1; SMN2TSHR | |
| SCHEMBL29035299 | 0.93 | LMNA (0.55) | GAAKDM4EMAPK1SMN1; SMN2TSHR | |
| SCHEMBL8947242 | 0.90 | KMT2A (0.67) | GAAKDM4EMAPK1SMN1; SMN2TSHR | |
| SCHEMBL5632141 | 0.90 | RAB9A (0.67) | GAAKDM4EMAPK1SMN1; SMN2TSHR | |
| SCHEMBL24224262 | 0.87 | KMT2A (0.59) | GAAKDM4EMAPK1SMN1; SMN2TSHR | |
| SCHEMBL30838576 | 0.87 | KDM4E (0.62) | GAAKDM4EMAPK1SMN1; SMN2TSHR | |
| SCHEMBL8947296 | 0.87 | MMP1 (0.68) | GAAKDM4EMAPK1SMN1; SMN2TSHR | |
| SCHEMBL5655365 | 0.86 | PRSS1 (0.68) | GAASMN1; SMN2MEN1KMT2APRSS1 | |
| SCHEMBL30571840 | 0.85 | KDM4E (0.51) | GAAKDM4EMAPK1SMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117425733-A | Substance detection method using acylated amino acid hydrolase | 学校法人常翔学园 | 2024-01-19 | — | — | CN | claimed |
| US-20210101128-A1 | SEPARATING COLUMN FOR HIPPURIC ACID ANALYSIS, LIQUID CHROMATOGRAPH FOR HIPPURIC ACID ANALYSIS, AND METHOD FOR ANALYZING HIPPURIC ACID | SHIMADZU CORPORATION (JP) | 2021-04-08 | — | — | US | claimed |
| CN-105461705-A | Dibenzo-azepine-dione anti-tumor compounds and preparation method thereof | UNIV CHINA MEDICAL | 2016-04-06 | — | — | CN | claimed |
| JP-61093956-A | — | — | None | — | — | JP | disclosed |
| CN-119684070-A | HFIP power assisting C (sp3) Direct methylation method of-H bond and application thereof | 西南大学 | 2025-03-25 | — | — | CN | disclosed |
| US-12097479-B2 | Separating column for separating hippuric acid and mandelic acid, liquid chromatograph for separating hippuric acid and mandelic acid, and method for analyzing hippuric acid and mandelic acid | SHIMADZU CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| CN-117946897-A | Strain Bacillus velezensis HS-3, culture medium for culturing strain and application of strain | 淮南师范学院 | 2024-04-30 | — | — | CN | disclosed |
| CN-117897149-A | 3, 4-methylenedioxymethamphetamine and related hallucinogens and uses thereof | 人类生物科学股份有限公司 | 2024-04-16 | — | — | CN | disclosed |
| CN-117425733-A | Substance detection method using acylated amino acid hydrolase | 学校法人常翔学园 | 2024-01-19 | — | — | CN | disclosed |
| US-11767292-B2 | Process for making beta 3 agonists and intermediates | MERCK SHARP & DOHME CORP. (US) | 2023-09-26 | — | — | US | disclosed |
| US-11767292-B2 | Process for making beta 3 agonists and intermediates | MERCK SHARP & DOHME CORP. (US) | 2023-09-26 | — | — | US | disclosed |
| CN-1099759-A | Piperazine derivatives | MERCK PATENT GMBH (DE) | 1995-03-08 | — | — | CN | disclosed |
| EP-0220923-B1 | Dipeptides and process | GRACE W R & CO (US) | 1994-04-27 | — | — | EP | disclosed |
| EP-0574028-A1 | Dipeptide analogs of aspertame and process to prepare them as well as a new preparation of aspertame | HAMPSHIRE CHEMICAL CORP. (US) | 1993-12-15 | — | — | EP | disclosed |
| US-4873359-A | Process for preparing as partyl-phenylalanine dipeptides | W. R. GRACE & CO. - CONN. (US) | 1989-10-10 | — | — | US | disclosed |
| US-4810817-A | ARTIFICIAL SWEETENERS | W. R. GRACE & CO. (US) | 1989-03-07 | — | — | US | disclosed |
| US-4710583-A | ENZYMATIC COUPLING OF PHENYLSERINE WITH ASPARTIC ACID; HYDROGENATION | W. R. GRACE & CO. (US) | 1987-12-01 | — | — | US | disclosed |
| EP-0220923-A2 | Dipeptides and process | W.R. Grace & Co.-Conn. (US) | 1987-05-06 | — | — | EP | disclosed |
| JP-S6193956-A | METHOD AND DEVICE FOR ANALYZING VITAL FLUID | HITACHI KYOWA KOGYO KK | 1986-05-12 | — | — | JP | disclosed |
| US-4362550-A | Herbicidal triazinones | ELI LILLY AND COMPANY (US) | 1982-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11767292-B2 | Process for making beta 3 agonists and intermediates | ADRB3, ADRB1, ADRB2 | GAA 2585/4885KDM4E 4359/4885MAPK1 1396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.